From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 CNY | -0.90% |
|
+0.91% | -25.23% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.23% | 871M | |
+9.94% | 4.81B | |
-32.21% | 3.6B | |
-1.43% | 3.09B | |
-25.09% | 2.62B | |
-11.46% | 2.27B | |
+36.65% | 1.82B | |
+37.15% | 1.41B | |
-16.01% | 1.38B | |
+40.95% | 1.37B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.